- Home
- OCGN vs TKNO Comparison
OCGN vs TKNO Comparison
Compare OCGN & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCGN
- TKNO
- Stock Information
- Founded
- OCGN 2013
- TKNO 1996
- Country
- OCGN United States
- TKNO United States
- Employees
- OCGN N/A
- TKNO N/A
- Industry
- OCGN Biotechnology: Biological Products (No Diagnostic Substances)
- TKNO Medicinal Chemicals and Botanical Products
- Sector
- OCGN Health Care
- TKNO Health Care
- Exchange
- OCGN Nasdaq
- TKNO Nasdaq
- Market Cap
- OCGN 252.4M
- TKNO 244.7M
- IPO Year
- OCGN N/A
- TKNO 2021
- Fundamental
- Price
- OCGN $0.91
- TKNO $7.33
- Analyst Decision
- OCGN Strong Buy
- TKNO Buy
- Analyst Count
- OCGN 3
- TKNO 2
- Target Price
- OCGN $5.67
- TKNO $5.00
- AVG Volume (30 Days)
- OCGN 4.3M
- TKNO 316.7K
- Earning Date
- OCGN 11-08-2024
- TKNO 11-07-2024
- Dividend Yield
- OCGN N/A
- TKNO N/A
- EPS Growth
- OCGN N/A
- TKNO N/A
- EPS
- OCGN N/A
- TKNO N/A
- Revenue
- OCGN $4,700,000.00
- TKNO $36,347,000.00
- Revenue This Year
- OCGN N/A
- TKNO $3.56
- Revenue Next Year
- OCGN N/A
- TKNO $13.31
- P/E Ratio
- OCGN N/A
- TKNO N/A
- Revenue Growth
- OCGN N/A
- TKNO N/A
- 52 Week Low
- OCGN $0.36
- TKNO $1.16
- 52 Week High
- OCGN $2.11
- TKNO $8.36
- Technical
- Relative Strength Index (RSI)
- OCGN 44.59
- TKNO 57.69
- Support Level
- OCGN $0.85
- TKNO $6.15
- Resistance Level
- OCGN $0.94
- TKNO $8.36
- Average True Range (ATR)
- OCGN 0.08
- TKNO 0.82
- MACD
- OCGN -0.01
- TKNO 0.01
- Stochastic Oscillator
- OCGN 19.64
- TKNO 62.13
About OCGN Ocugen Inc.
Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").
About TKNO Alpha Teknova Inc.
Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its product offerings include pre-poured media plates for cell growth and cloning, liquid cell culture media and supplements for cellular expansion, and molecular biology reagents for sample manipulation, resuspension, and purification. It derives maximum revenue from United States.